Passive smoking and platelet thromboxane

Thrombosis Research

Volumn 81, Issue 4, 1996, Pages 451-460

  Schmid, Peter ^a   Karanikas, Georg ^e   Kritz, Harald ^b   Pirich, Christian ^a   Stamatopoulos, Yannis ^a   Peskar, Bernhard A ^c   Sinzinger, Helmut ^a,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b Rehab Center Engelsbad Melanie   (Austria)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^e NONE

Author keywords

passive smoking; platelet thromboxane

Indexed keywords

THROMBOXANE A2;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0029875851     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00017-5     Document Type: Article

References (41)

1. US PUBLIC HEALTH SERVICE. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. DHHS (PHS), 84-50204, 1983.
2. ROSS, R. and GLOMSET, J. A. The pathogenesis of atherosclerosis. N Engl J Med 295, 369-374, 1976.
3. STEENLAND, K. Passive smoking and the risk of heart disease. JAMA 267, 94-99, 1992.
4. KRUPSKI, W. C. The peripheral vascular consequences of smoking. Ann Vasc Surg 5, 291-304, 1991.
5. BURGHUBER, O.C., PUNZENGRUBER, C., SINZINGER, H., HABER, P., and SILBERBAUER, K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest 90, 34-38, 1985.
6. SINZINGER, H. The effect of cigarette smoking on platelet function and hemostatic balance in healthy people. Thromb Haemost 51, 296, 1984.
7. HAWKINS, P. Smoking, platelets and thrombosis. Nature 236, 450-462, 1972.
8. SINZINGER, H. and VIRGOLINI, I. Besitzen Passivraucher ein erhöhtes Thromboserisiko ? Wr Klin Wochenschr 101, 694-698, 1989.
9. FITZ GERALD, G.A., OATES, J.A. and NOWAK, J. Cigarette smoking and hemostatic function. Am Heart J 115, 267-271, 1988.
10. DAVIS, J.W. and ARNOLD, J. Time course of some effects of cigarette smoking on platelets. J Intern Med 231, 31-36, 1992.
11. GLANTZ, ST. A. and PARMLEY, W. W. Passive smoking and heart disease -epidemiology, physiology and biochemistry. Circulation 83, 1-12, 1991.
12. SIEGEL, M. Involuntary smoking in the restaurant workplace-a review of employee exposure and health effects. JAMA 270, 490-493, 1993.
13. CHAPMAN, S. Unravelling gossamer with boxing gloves-problems in explaining the decline in smoking. BMJ 307, 429-432, 1993.
14. BOS, R.P. and HENDERSON, P.T. Genotoxic risk of passive smoking. Rev Environ Health 4, 161-178, 1984.
15. LESMES, G.R. and DONOFRIO, K.H. Passive smoking: the medical and economic issue. Am J Med 15, Suppl I, 38-42, 1992.
16. LEONE, A. Cardiovascular damage from smoking: a fact or belief? Int J Cardiol 38, 113-117, 1993.
17. GARLAND, C., BARRETT-CONNOR, E., SUAREZ, L., CRIQUI, M.H. and WINGARD, D.L. Effects of passive smoking on ischemic heart disease mortality of non-smokers. A prospective study. Am J Epidemiol 121, 645-650, 1985.
18. SHAHAM, J., RIBAK, J. and GREEN, M. The consequences of passive smoking: an overview. Public Health Rev 20, 15-28, 1992-1993.
19. SINZINGER, H., REITER, S. and PESKAR, B. A. Removal, preparation and storage of human plasma for radioimmunological detection of prostaglandins. In: Prostaglandins and Other Eicosanoids in the Cardiovascular System. K. Schrör (ed.), pp. 62-67, Karger, Basel (1985).
20. STERNBY, N.H. Atherosclerosis, smoking and other risk factors. In: Atherosclerosis V. A.M. Gotto Jr, L.C. Smith and B. Allen (eds.), pp. 67-70, Springer Verlag, New York (1980).
21. LAKIER, J.B. Smoking and cardiovascular disease. Am J Med 93, Suppl I, 8-12, 1992.
22. SINZINGER, H. and KEFALIDES, A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet ii, 392-393, 1982.
23. ZHU, B.Q., SUN, Y.P., SIEVERS, R.E., ISENBERG, W.M., GLANTZ, ST.A and PARMLEY, W.W. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 21, 225-232, 1993
24. PUMPHREY, C.W. and DAWES, J. Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings xn ischemic heart disease and after acute myocardial infarction. Am J Cardiol 50, 1258-1261, 1982.
25. MARASINI, B., BIONDI, M.L., BARBESTI, S., ZATTA, G. and AGOSTONI, A. Cigarette smoking and platelet function. Thromb Res 44, 85-94, 1986.
26. DOTEVALL, A., KUTTI, J., TEGER-NILSSON, A.C., WADENVIK, H. and WILHELMSEN, L. Platelet reactivity, fibrinogen and smoking. Eur J Haematol 38, 55-59, 1987.
27. WENNMALM, A. Interaction of nicotine and prostaglandins in the cardiovascular system. Prostaglandins 23, 139-144, 1982.
28. SINZINGER, H., SCHERNTHANER, G. and KALIMAN, J. Sensitivity of platelets to prostaglandins in coronary heart disease and angina pectoris. Prostaglandins 22, 773-776, 1981.
29. MOORE, S. The role of platelets in the early stages of atherosclerosis. In: Platelets and Atherosclerosis. Ch. Kessler (ed.), pp. 1-9, Springer Verlag, Berlin, Heidelberg (1990).
30. DAVIS, J.W., SHELTON, L., WATANABE, T.S. and ARNOLD, J. Passive smoking affects endothelium and platelets. Arch Intern Med 149, 386-389, 1989.
31. DAVIS, J.W., SHELTON, L., EIGENBERG, D.A., HIGNITE, C. and WATANABE, I. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37, 529-533, 1985.
32. DAVIS, J.W., SHELTON, L., HARTMAN, C.R., EIGENBERG, D. and RUTTINGER, H. Smoking induced changes in endothelium and platelets are not affected by hydroxyethylrutosides. Br J Exp Pathol 67, 765-771, 1986.
33. DAVIS, J.W., SHELTON, L. and EIGENBERG, D. A. Lack of effect of aspirin on cigarette smoke-induced increase in circulating endothelial cells. Haemostasis 17, 66-69, 1987.
34. DAVIS, J.W., HARTMANN, C.R., LEWIS JR, H.D., SHELTON, L., EIGENBERG, D., HASSANEIN, K., HIGNITE, C. and RUTTINGER, H. Cigarette smoking-induced enhancement of platelet function: Lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 105, 479-483, 1985.
35. RIVERS, R.P.A., HATHAWAY, W.E. and WESTON, W.L. The endotoxine-induced coagulant activity of human monocytes. Br J Haematol 30, 311-316, 1975.
36. OSTERYUD, B., LINDAHL, U. and SELJELID, R. Macrophages produce coagulant factors FEBS Lett 120, 41-43, 1980.
37. CHANDLER, A.B. and HAND, R.A. Phagocytized platelets: a source of lipids in human thrombi and atherosclerotic plaques. Science 134, 946-949, 1961.
38. FOGELMAN, A.M., SHECHTER, I., SEAGER, J., HOKOM, M., CHILD, J.S. and EDWARDS P.A. Malondialdehyd alteration of low density lipoprotein leads to cholesteryl ester accumulation in human monocyte-macrophage. Proc Natl Acad Sci USA 77, 269-271, 1980.
39. HODENBERG VON, E., HEINEN, S., HAUPTMANN, M., KREUZER, J., HENNINGSEN, H. and KUBLER, W. The role of macrophages in atherogenesis-platelet/monocyte interactions. In: Platelets and Atherosclerosis. Ch. Kessler (ed.), pp. 19-24, Springer Verlag, Berlin, Heidelberg (1990).
40. SCHEFFLER, E., WIEST, E., WOEHRLE, J., OTTO, I., SCHULZ, I., HUBER, L., ZIEGLER, R. and DRESEL, H.A. Smoking influences the atherogenic potential of low-density lipoprotein. Clin Investig 70, 263-268, 1992
41. 2 formation without affecting platelet survival in young healthy females. Thromb Haemost 68, 583-588, 1992.